BAZ2A _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018747
Fusion event
HBV-BAZ2A integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2017
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
480
End
579
Integrated sequence
CTAATTCCAGGATCCTCAACAACCAGCACGGGACCATGCCGGACCTGCATGACTACTGCTCAAGGAACCTCTATGTATCCCTCCTGTTGCTGTACCAAAC
Host Sequence
Chromosome
chr12
Cytoband
q13.3
Reference genome
End
57008797/56615013 (Hg38)
Location type
Exon27
Target gene
miRNAs that regulate target gene
hsa-mir-1180-3p ; hsa-mir-877-3p ; hsa-mir-671-5p ; hsa-mir-425-5p ; hsa-mir-484 ; hsa-mir-328-3p ; hsa-mir-27b-3p ; hsa-mir-93-5p ; hsa-mir-23a-3p ; hsa-mir-17-5p ; hsa-let-7b-5p ; hsa-let-7a-5p ; hsa-mir-4755-3p ; hsa-mir-485-5p ; hsa-mir-3188 ; hsa-mir-3975 ; hsa-mir-2467-5p ; hsa-mir-6884-5p ; hsa-mir-3915 ; hsa-mir-486-3p ; hsa-mir-874-5p ; hsa-mir-3928-3p ; hsa-mir-4699-5p ; hsa-mir-6805-5p ; hsa-mir-5680 ; hsa-mir-451b ; hsa-mir-548e-5p ; hsa-mir-449a ; hsa-mir-34a-5p ; hsa-mir-34c-5p ; hsa-mir-449b-5p ; hsa-mir-5006-5p ; hsa-mir-3972 ; hsa-mir-1202 ; hsa-mir-3144-3p ; hsa-mir-4668-5p ; hsa-mir-625-5p ; hsa-mir-3148 ; hsa-mir-6798-5p ; hsa-mir-6794-5p ; hsa-mir-4716-3p ; hsa-mir-6783-5p ; hsa-mir-6753-5p ; hsa-mir-1911-3p ; hsa-mir-3157-5p ; hsa-mir-4423-3p ; hsa-mir-4722-5p ; hsa-mir-4691-3p ; hsa-mir-449c-5p ; hsa-mir-34b-5p ; hsa-mir-2682-5p ; hsa-mir-940 ; hsa-mir-6893-5p ; hsa-mir-6808-5p ; hsa-mir-6511a-5p ; hsa-mir-1910-3p ; hsa-mir-512-5p ; hsa-mir-4304 ; hsa-mir-4253 ; hsa-mir-6079 ; hsa-mir-4669 ; hsa-mir-198 ; hsa-mir-4634 ; hsa-mir-4745-3p ; hsa-mir-1538 ; hsa-mir-6828-5p ; hsa-mir-4783-3p ; hsa-mir-6837-5p ; hsa-mir-4685-5p ; hsa-mir-3918 ; hsa-mir-7113-5p ; hsa-mir-7160-3p ; hsa-mir-4802-3p ; hsa-mir-15b-5p ; hsa-mir-16-5p ; hsa-mir-497-5p ; hsa-mir-424-5p ; hsa-mir-195-5p ; hsa-mir-6838-5p ; hsa-mir-15a-5p ; hsa-mir-103a-3p ; hsa-mir-107 ; hsa-mir-6873-3p ; hsa-mir-6817-3p ; hsa-mir-7110-3p ; hsa-mir-7162-3p ; hsa-mir-4649-3p ; hsa-mir-301b-5p ; hsa-mir-301a-5p ; hsa-mir-146a-3p ; hsa-mir-642b-3p ; hsa-mir-642a-3p ; hsa-mir-6730-3p ; hsa-mir-4653-5p ; hsa-mir-3921 ; hsa-mir-4478 ; hsa-mir-4419b ; hsa-mir-3929 ; hsa-mir-6089 ; hsa-mir-5008-5p ; hsa-mir-8485 ; hsa-mir-193a-3p ; hsa-mir-193b-3p ; hsa-mir-181d-5p ; hsa-mir-181c-5p ; hsa-mir-181b-5p ; hsa-mir-181a-5p
Nearest miRNA
hsa-mir-1244-3/Upstream/2277699; hsa-let-7i/Downstream/579491;
Upstream sequence
TCTCCCAAGTGTATCACATGATATGATGTGTGCAGGTGTCAGATGATGCTGAGATGGCCGACAGAGCTCAATTCAGAAACAAGTGATGAGCTCCTTAACA
Downstream sequence
TACTCCACTTCTCTTCAAGATTCAGTTCATCATTGTACCCTAACAACCTCCACCCTCTCTCTTCTACGCTGCCTCTTGCTGGCCAAATCCAACAACCATA
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Curate